Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 85 Osteosarcoma 30 Neuroectodermal Tumors, Primitive, Peripheral 16 Fibrosarcoma 16 Rhabdomyosarcoma 14 Liposarcoma 14 Hemangiosarcoma 13 Neurofibrosarcoma 12 Leiomyosarcoma 12 Histiocytoma, Malignant Fibrous 12 Sarcoma, Synovial 11 Malignant mesenchymal tumor 9 Sarcoma, Ewing 8 Ovarian Neoplasms 8 Hemangiopericytoma, Malignant 8 Kidney Neoplasms 6 Dendritic Cell Sarcoma, Interdigitating 6 Wilms Tumor 5 Sarcoma, Alveolar Soft Part 5 Neoplasms 5 Desmoplastic Small Round Cell Tumor 5 Chondrosarcoma 5 Carcinoma, Renal Cell 5 Neuroblastoma 4 Neoplasm Metastasis 4 Medulloblastoma 4 Lymphoma, Large B-Cell, Diffuse 4 Dermatofibrosarcoma 4 Chondrosarcoma, Extraskeletal Myxoid 4 Central Nervous System Neoplasms 4

Interventions

Diathermy 3 Surgical Procedures, Operative 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Melphalan 1 Ifosfamide 1 Doxorubicin 1 Dacarbazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperthermia × Ifosfamide × Sarcoma × Clear all

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡